---
title: Core Stability as a Prognostic Factor of Urinary Incontinence in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
nct_id: NCT05893394
overall_status: UNKNOWN
sponsor: Istituto Clinico Humanitas
study_type: OBSERVATIONAL
primary_condition: Prostate Cancer
countries: Italy
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05893394.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05893394"
ct_last_update_post_date: 2023-06-07
last_seen_at: "2026-05-12T07:07:31.885Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Core Stability as a Prognostic Factor of Urinary Incontinence in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy

**NCT ID:** [NCT05893394](https://clinicaltrials.gov/study/NCT05893394)

## Key Facts

- **Status:** UNKNOWN
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 62
- **Lead Sponsor:** Istituto Clinico Humanitas
- **Conditions:** Prostate Cancer
- **Start Date:** 2023-03-01
- **Completion Date:** 2023-11-30
- **CT.gov Last Update:** 2023-06-07

## Brief Summary

The study aims at investigating the possible correlation between core stability muscles and urinary incontinence following Robot-Assisted Laparoscopic Prostatectomy.

Sixty-two patients who are candidates for Robot-Assisted Laparoscopic Prostatectomy will be enrolled. All participants will be asked to be evaluated in their core stability functionality 30-40 days before Robot-Assisted Laparoscopic Prostatectomy intervention. The core stability functionality result will be correlated with the urinary incontinence 45-50 days after intervention.

## Detailed Description

The study aims at investigating the correlation between core stability muscles and urinary incontinence following Robot-Assisted Laparoscopic Prostatectomy.

All sixty-two participants will be asked to be evaluated in their core stability functionality 30-40 days before Robot-Assisted Laparoscopic Prostatectomy intervention. Core stability functionality will be evaluated through the Loumajoki Battery of tests, composed of 10 simple items in which the patients have to maintain core stability. In addition a Quality of Life questionnaire (WHO Quality of Life-BREF) will be administered. The core stability functionality result will be correlated with urinary incontinence measured by the 24h PAD test 45-50 days after intervention. At this point core stability will be evaluated again as done before.

## Eligibility

- **Sex:** MALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Patient who are candidates for Robot-Assisted Laparoscopic Prostatectomy
* Objectivity of core muscles recruitment through the Loumajoki Battery

Exclusion Criteria:

* Pre-surgery incontinence
* Pre-intervention radiotherapy treatment
* Previous urogenital surgery
* Concomitant presence of neurological, internal medicine or musculoskeletal system pathologies that may affect functional or motor recovery
* Subjects with cognitive deficits and/or psychiatric disorders
* Lumbar stabilization or abdominal interventions
* Acute low back pain
```

## Primary Outcomes

- **Correlation between Core stability functionality and Urinary Incontinence.** _(time frame: Core stability evaluated 30-40 days before surgery. Urinary incontinence evaluated 45-50 days after surgery)_ — To evaluate any correlation between Core stability functionality measured with Loumajoki Battery and Urinary Incontinence measured with 24h PAD test.

## Secondary Outcomes

- **Correlation between Core stability functionality and Quality of Life.** _(time frame: Core stability evaluated 30-40 days before surgery. Quality of Life evaluated 30-40 days before surgery)_
- **Variation between Core stability functionality at base line and at follow-up.** _(time frame: Core stability evaluated 30-40 days before surgery and 45-50 days after surgery)_

## Locations (1)

- Istituto Clinico Humanitas, Rozzano, Italy — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.istituto clinico humanitas|rozzano||italy` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05893394.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05893394*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*